RH — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that RH filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2012 | Feb 2, 2013 | $1.19B | Apr 29, 2013 |
| FY2012 | Jan 28, 2012 | $958.08M | Apr 29, 2013 |
| FY2012 | Jan 29, 2011 | $772.75M | Apr 29, 2013 |
Revenue
Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2020 | Jan 30, 2021 | $812.44M | Mar 30, 2021 |
| FY2020 | Oct 31, 2020 | $844.01M | Mar 30, 2021 |
| FY2020 | Aug 1, 2020 | $709.28M | Mar 30, 2021 |
| FY2020 | May 2, 2020 | $482.90M | Mar 30, 2021 |
| FY2020 | Feb 1, 2020 | $664.98M | Mar 30, 2021 |
| FY2020 | Nov 2, 2019 | $677.53M | Mar 30, 2021 |
| FY2020 | Aug 3, 2019 | $706.51M | Mar 30, 2021 |
| FY2020 | May 4, 2019 | $598.42M | Mar 30, 2021 |
| FY2019 | Feb 2, 2019 | $670.89M | Mar 30, 2020 |
| FY2019 | Nov 3, 2018 | $636.56M | Mar 30, 2020 |
Revenue (Net Sales)
Net sales revenue — gross revenue less returns, allowances, and discounts. Used by many manufacturers and retailers as the primary top-line figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2017 | Feb 3, 2018 | $670.30M | Mar 29, 2018 |
| FY2017 | Oct 28, 2017 | $592.47M | Mar 29, 2018 |
| FY2017 | Jul 29, 2017 | $615.33M | Mar 29, 2018 |
| FY2017 | Apr 29, 2017 | $562.08M | Mar 29, 2018 |
| FY2017 | Jan 28, 2017 | $586.71M | Mar 29, 2018 |
| FY2017 | Oct 29, 2016 | $549.33M | Mar 29, 2018 |
| FY2017 | Jul 30, 2016 | $543.38M | Mar 29, 2018 |
| FY2017 | Apr 30, 2016 | $455.46M | Mar 29, 2018 |
| FY2016 | Jan 30, 2016 | $647.21M | Mar 29, 2017 |
| FY2016 | Oct 31, 2015 | $532.41M | Mar 29, 2017 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jan 31, 2026 | $1.52B | Apr 1, 2026 |
| FY2025 | Feb 1, 2025 | $1.41B | Apr 1, 2026 |
| FY2025 | Feb 3, 2024 | $1.39B | Apr 1, 2026 |
| FY2024 | Jan 28, 2023 | $1.81B | Apr 2, 2025 |
| FY2024 | Jan 29, 2022 | $1.86B | Mar 28, 2024 |
| FY2020 | Jan 30, 2021 | $385.13M | Mar 30, 2021 |
| FY2020 | Oct 31, 2020 | $408.33M | Mar 30, 2021 |
| FY2020 | Aug 1, 2020 | $332.42M | Mar 30, 2021 |
| FY2020 | May 2, 2020 | $199.65M | Mar 30, 2021 |
| FY2020 | Feb 1, 2020 | $283.07M | Mar 30, 2021 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jan 31, 2026 | $124.79M | Apr 1, 2026 |
| FY2025 | Feb 1, 2025 | $72.41M | Apr 1, 2026 |
| FY2025 | Feb 3, 2024 | $127.56M | Apr 1, 2026 |
| FY2024 | Jan 28, 2023 | $528.64M | Apr 2, 2025 |
| FY2024 | Jan 29, 2022 | $688.55M | Mar 28, 2024 |
| FY2020 | Jan 30, 2021 | $130.19M | Mar 30, 2021 |
| FY2020 | Oct 31, 2020 | $46.41M | Mar 30, 2021 |
| FY2020 | Aug 1, 2020 | $98.42M | Mar 30, 2021 |
| FY2020 | May 2, 2020 | ($3.21M) | Mar 30, 2021 |
| FY2020 | Feb 1, 2020 | $68.43M | Mar 30, 2021 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jan 31, 2026 | $387.27M | Apr 1, 2026 |
| FY2025 | Feb 1, 2025 | $322.59M | Apr 1, 2026 |
| FY2025 | Feb 3, 2024 | $366.07M | Apr 1, 2026 |
| FY2024 | Jan 28, 2023 | $722.16M | Apr 2, 2025 |
| FY2024 | Jan 29, 2022 | $927.18M | Mar 28, 2024 |
| FY2023 | Jan 30, 2021 | $466.86M | Mar 29, 2023 |
| FY2021 | Feb 1, 2020 | $362.83M | Mar 30, 2022 |
| FY2020 | Feb 2, 2019 | $261.74M | Mar 30, 2021 |
| FY2019 | Feb 3, 2018 | $117.12M | Mar 30, 2020 |
| FY2018 | Jan 28, 2017 | $53.04M | Mar 29, 2019 |
SG&A Expense
Selling, general, and administrative expenses — the overhead costs of running the business, including salaries, marketing, legal fees, and corporate office costs. Excludes COGS and R&D.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jan 31, 2026 | $1.13B | Apr 1, 2026 |
| FY2025 | Feb 1, 2025 | $1.09B | Apr 1, 2026 |
| FY2025 | Feb 3, 2024 | $1.02B | Apr 1, 2026 |
| FY2024 | Jan 28, 2023 | $1.09B | Apr 2, 2025 |
| FY2024 | Jan 29, 2022 | $928.23M | Mar 28, 2024 |
| FY2023 | Jan 30, 2021 | $858.67M | Mar 29, 2023 |
| FY2021 | Feb 1, 2020 | $732.18M | Mar 30, 2022 |
| FY2020 | Feb 2, 2019 | $723.84M | Mar 30, 2021 |
| FY2019 | Feb 3, 2018 | $722.18M | Mar 30, 2020 |
| FY2018 | Jan 28, 2017 | $626.75M | Mar 29, 2019 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jan 31, 2026 | $452.24M | Apr 1, 2026 |
| FY2025 | Feb 1, 2025 | $17.10M | Apr 1, 2026 |
| FY2025 | Feb 3, 2024 | $202.21M | Apr 1, 2026 |
| FY2024 | Jan 28, 2023 | $403.69M | Apr 2, 2025 |
| FY2024 | Jan 29, 2022 | $662.11M | Mar 28, 2024 |
| FY2023 | Jan 30, 2021 | $500.77M | Mar 29, 2023 |
| FY2021 | Feb 1, 2020 | $339.19M | Mar 30, 2022 |
| FY2020 | Feb 2, 2019 | $249.60M | Mar 30, 2021 |
| FY2019 | Feb 3, 2018 | $474.51M | Mar 30, 2020 |
| FY2018 | Jan 28, 2017 | $80.51M | Mar 29, 2019 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jan 31, 2026 | $199.84M | Apr 1, 2026 |
| FY2025 | Feb 1, 2025 | $230.79M | Apr 1, 2026 |
| FY2025 | Feb 3, 2024 | $269.36M | Apr 1, 2026 |
| FY2024 | Jan 28, 2023 | $173.64M | Apr 2, 2025 |
| FY2024 | Jan 29, 2022 | $185.38M | Mar 28, 2024 |
| FY2023 | Jan 30, 2021 | $111.13M | Mar 29, 2023 |
| FY2021 | Feb 1, 2020 | $93.62M | Mar 30, 2022 |
| FY2020 | Feb 2, 2019 | $79.99M | Mar 30, 2021 |
| FY2019 | Feb 3, 2018 | $68.39M | Mar 30, 2020 |
| FY2018 | Jan 28, 2017 | $170.03M | Mar 29, 2019 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jan 31, 2026 | $4.84B | Apr 1, 2026 |
| FY2025 | Feb 1, 2025 | $4.55B | Apr 1, 2026 |
| FY2024 | Feb 3, 2024 | $4.14B | Apr 2, 2025 |
| FY2024 | Jan 28, 2023 | $5.31B | Mar 28, 2024 |
| FY2023 | Jan 29, 2022 | $5.54B | Mar 29, 2023 |
| FY2021 | Jan 30, 2021 | $2.90B | Mar 30, 2022 |
| FY2020 | Feb 1, 2020 | $2.45B | Mar 30, 2021 |
| FY2019 | Feb 2, 2019 | $2.42B | Mar 30, 2020 |
| FY2018 | Feb 3, 2018 | $1.73B | Mar 29, 2019 |
| FY2017 | Jan 28, 2017 | $2.19B | Mar 29, 2018 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jan 31, 2026 | $4.78B | Apr 1, 2026 |
| FY2025 | Feb 1, 2025 | $4.72B | Apr 1, 2026 |
| FY2024 | Feb 3, 2024 | $4.44B | Apr 2, 2025 |
| FY2024 | Jan 28, 2023 | $4.52B | Mar 28, 2024 |
| FY2023 | Jan 29, 2022 | $4.37B | Mar 29, 2023 |
| FY2021 | Jan 30, 2021 | $2.45B | Mar 30, 2022 |
| FY2020 | Feb 1, 2020 | $2.43B | Mar 30, 2021 |
| FY2019 | Feb 2, 2019 | $2.46B | Mar 30, 2020 |
| FY2018 | Feb 3, 2018 | $1.74B | Mar 29, 2019 |
| FY2017 | Jan 28, 2017 | $1.27B | Mar 29, 2018 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jan 31, 2026 | $60.60M | Apr 1, 2026 |
| FY2025 | Feb 1, 2025 | ($163.59M) | Apr 1, 2026 |
| FY2025 | Feb 3, 2024 | ($297.39M) | Apr 1, 2026 |
| FY2025 | Jan 28, 2023 | $784.66M | Apr 1, 2026 |
| FY2024 | Jan 29, 2022 | $1.17B | Apr 2, 2025 |
| FY2024 | Jan 30, 2021 | $447.03M | Mar 28, 2024 |
| FY2023 | Feb 1, 2020 | $18.65M | Mar 29, 2023 |
| FY2021 | Feb 2, 2019 | ($38.69M) | Mar 30, 2022 |
| FY2018 | Aug 4, 2018 | $146.06M | Mar 29, 2019 |
| FY2018 | May 5, 2018 | $8.64M | Mar 29, 2019 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jan 31, 2026 | $144.24M | Apr 1, 2026 |
| FY2025 | Feb 1, 2025 | $140.94M | Apr 1, 2026 |
| FY2024 | Feb 3, 2024 | $141.03M | Apr 2, 2025 |
| FY2024 | Jan 28, 2023 | $141.05M | Mar 28, 2024 |
| FY2023 | Jan 29, 2022 | $141.10M | Mar 29, 2023 |
| FY2021 | Jan 30, 2021 | $141.10M | Mar 30, 2022 |
| FY2020 | Feb 1, 2020 | $124.37M | Mar 30, 2021 |
| FY2019 | Feb 2, 2019 | $124.38M | Mar 30, 2020 |
| FY2018 | Feb 3, 2018 | $141.89M | Mar 29, 2019 |
| FY2017 | Jan 28, 2017 | $173.60M | Mar 29, 2018 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jan 31, 2026 | ($386.07M) | Apr 1, 2026 |
| FY2025 | Feb 1, 2025 | ($510.85M) | Apr 1, 2026 |
| FY2024 | Feb 3, 2024 | ($583.26M) | Apr 2, 2025 |
| FY2024 | Jan 28, 2023 | $539.99M | Mar 28, 2024 |
| FY2023 | Jan 29, 2022 | $551.11M | Mar 29, 2023 |
| FY2021 | Jan 30, 2021 | ($137.44M) | Mar 30, 2022 |
| FY2020 | Feb 1, 2020 | ($409.25M) | Mar 30, 2021 |
| FY2019 | Feb 2, 2019 | ($392.54M) | Mar 30, 2020 |
| FY2018 | Aug 4, 2018 | $223.46M | Mar 29, 2019 |
| FY2018 | May 5, 2018 | $159.42M | Mar 29, 2019 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jan 31, 2026 | $41.19M | Apr 1, 2026 |
| FY2025 | Feb 1, 2025 | $30.41M | Apr 1, 2026 |
| FY2025 | Feb 3, 2024 | $123.69M | Apr 1, 2026 |
| FY2025 | Jan 28, 2023 | $1.51B | Apr 1, 2026 |
| FY2024 | Jan 29, 2022 | $2.18B | Apr 2, 2025 |
| FY2024 | Jan 30, 2021 | $100.45M | Mar 28, 2024 |
| FY2023 | Feb 1, 2020 | $47.66M | Mar 29, 2023 |
| FY2021 | Feb 2, 2019 | $5.80M | Mar 30, 2022 |
| FY2020 | Feb 3, 2018 | $17.91M | Mar 30, 2021 |
| FY2019 | Jan 28, 2017 | $87.02M | Mar 30, 2020 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jan 31, 2026 | 6 | Apr 1, 2026 |
| FY2025 | Feb 1, 2025 | 3 | Apr 1, 2026 |
| FY2025 | Feb 3, 2024 | 6 | Apr 1, 2026 |
| FY2024 | Jan 28, 2023 | 22 | Apr 2, 2025 |
| FY2024 | Jan 29, 2022 | 32 | Mar 28, 2024 |
| FY2020 | Jan 30, 2021 | 6 | Mar 30, 2021 |
| FY2020 | Oct 31, 2020 | 2 | Mar 30, 2021 |
| FY2020 | Aug 1, 2020 | 5 | Mar 30, 2021 |
| FY2020 | May 2, 2020 | 0 | Mar 30, 2021 |
| FY2020 | Feb 1, 2020 | 3 | Mar 30, 2021 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jan 31, 2026 | 6 | Apr 1, 2026 |
| FY2025 | Feb 1, 2025 | 3 | Apr 1, 2026 |
| FY2025 | Feb 3, 2024 | 5 | Apr 1, 2026 |
| FY2024 | Jan 28, 2023 | 19 | Apr 2, 2025 |
| FY2024 | Jan 29, 2022 | 22 | Mar 28, 2024 |
| FY2020 | Jan 30, 2021 | 4 | Mar 30, 2021 |
| FY2020 | Oct 31, 2020 | 1 | Mar 30, 2021 |
| FY2020 | Aug 1, 2020 | 3 | Mar 30, 2021 |
| FY2020 | May 2, 2020 | 0 | Mar 30, 2021 |
| FY2020 | Feb 1, 2020 | 2 | Mar 30, 2021 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jan 31, 2026 | 18.82M | Apr 1, 2026 |
| FY2025 | Feb 1, 2025 | 18.73M | Apr 1, 2026 |
| FY2024 | Feb 3, 2024 | 18.32M | Apr 2, 2025 |
| FY2024 | Jan 28, 2023 | 22.05M | Mar 28, 2024 |
| FY2023 | Jan 29, 2022 | 21.51M | Mar 29, 2023 |
| FY2021 | Jan 30, 2021 | 21.00M | Mar 30, 2022 |
| FY2020 | Feb 1, 2020 | 19.24M | Mar 30, 2021 |
| FY2019 | Feb 2, 2019 | 20.48M | Mar 30, 2020 |
| FY2018 | Feb 3, 2018 | 21.52M | Mar 29, 2019 |
| FY2017 | Jan 28, 2017 | 40.83M | Mar 29, 2018 |